Zurcher Kantonalbank (Zurich Cantonalbank) Vaxart, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 03, 2021	SELL	$5.64 - $23.33 $55,164 - $228,190	-9,781 Reduced 39.04%	15,276 $92,000
Q4 2020 Jan 28, 2021	BUY	$3.5 - $7.98 $87,699 - $199,954	25,057 New	25,057 $143,000

Others Institutions Holding VXRT

# of Institutions

108

Shares Held

37.9M

Call Options Held

188K

Put Options Held

180K

Sio Capital Management, LLC New York, NY

13.6M
Shares

$10.1 Million
6.11% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$7.46 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.97M
Shares

$2.94 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.54M
Shares

$1.88 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.77M
Shares

$1.31 Million
0.0% of portfolio

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account